LV12342B - Progesterons išēmijas ārstēšanai vai mazināšanai - Google Patents
Progesterons išēmijas ārstēšanai vai mazināšanai Download PDFInfo
- Publication number
- LV12342B LV12342B LVP-99-88A LV990088A LV12342B LV 12342 B LV12342 B LV 12342B LV 990088 A LV990088 A LV 990088A LV 12342 B LV12342 B LV 12342B
- Authority
- LV
- Latvia
- Prior art keywords
- ischemia
- progesterone
- pharmaceutical preparation
- myocardial ischemia
- preparation according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (24)
- LV 12342 IZGUDROJUMA FORMULA 1. Farmaceitisks preparāts išēmijas ārstēšanai vai remisijai raksturīgs arto, ka ietver progesteronu.
- 2. Farmaceitisks preparāts saskaņā ar 1. punktu, r a k s t u r ī g s ar to, ka išēmija ir miokarda išēmija.
- 3. Farmaceitisks preparāts saskaņā ar 2. punktu, r a k s t u r ī g s ar to, ka išēmiju ir izsaukusi piepūle.
- 4. Farmaceitisks preparāts išēmijas remisijai estrogēna terapijas labvēlīgās ietekmes palielināšanai, r a k s t u r ī g s ar to, ka ietver progesteronu.
- 5. Farmaceitisks preparāts saskaņā ar 4. punktu, r a k s t u r ī g s ar to, ka išēmija ir miokarda išēmija.
- 6. Farmaceitisks preparāts saskaņā ar 5. punktu, r a k s t u r ī g s ar to, ka miokarda išēmiju ir izsaukusi piepūle.
- 7. Farmaceitisks preparāts saskaņā ar 6. punktu, r a k s t u r ī g s ar to, ka ietver strukturētu polikarbonskābes polimēru, kuru ievada sievietei vaginālā veidā ar zāļu formu.
- 8. Farmaceitisks preparāts saskaņā ar 7. punktu, r a k s t u r ī g s ar to, ka polimērs ir polikarbofīls.
- 9. Farmaceitisks preparāts saskaņā ar 7. punktu, r a k s t u r ī g s ar to, ka sieviete ir menopauzē.
- 10. Farmaceitisks preparāts ar 1. punktu, r a k s t u r ī g s ar to, ka to izmanto kad pacients ir pakļauts estrogēna terapijai.
- 11. Farmaceitisks preparāts saskaņā ar 2. punktu, r a k s t u r ī g s ar to, ka to izmanto kad pacients ir pakļauts estrogēna terapijai.
- 12. Farmaceitisks preparāts saskaņā ar 3. punktu, r a k s t u r ī g s ar to, ka to izmanto kad pacients ir pakļauts estrogēna terapijai.
- 13. Farmaceitisks preparāts saskaņā ar 11. punktu, r a k s t u r ī g s ar to, ka to izmanto kad estrogēna terapija domāta miokarda išēmijas ārstēšanai.
- 14. Farmaceitisks preparāts saskaņā ar 12. punktu, r a k s t u r ī g s ar to, ka to izmanto kad estrogēna terapija domāta piepūles izsauktas miokarda išēmijas ārstēšanai. 2
- 15. Farmaceitisks preparāts koronāro artēriju slimību ārstēšanai vai remisijai, r a k s t u r ī g s ar to, ka ietver progesteronu.
- 16. Farmaceitisks preparāts sirds-asinsvadu saslimšanas gadījumu ārstēšanai vai remisijai, r a k s t u r ī g s ar to, ka ietver progesteronu.
- 17. Progesterona izmantošana farmaceitiskas kompozīcijas izgatavošanai išemijas ārstēšanai vai remisijai.
- 18. Izmantošana saskaņā ar 17. punktu, kur išēmija ir miokarda išēmija.
- 19. Izmantošana saskaņā ar 18. punktu, kur miokarda išēmija ir piepūles izsauktā miokarda išēmija.
- 20. Progesterona izmantošana farmaceitiskas kompozīcijas izgatavošanai, kas domāta išēmijas remisijai izmantotās estrogēna terapijas labvēlīgās iedarbības saglabāšanai vai palielināšanai.
- 21. Izmantošana saskaņā ar 20. punktu, kur išēmija ir miokarda išēmija.
- 22. Izmantošana saskaņā ar 21. punktu, kur miokarda išēmija ir piepūles izsauktā miokarda išēmija.
- 23. Progesterona un strukturētā polikarbonskābes polimēra izmantošana išēmijas ārstēšanai vai remisijai domātas farmaceitiskas kompozīcijas pagatavošanai.
- 24. Izmantošana saskaņā ar 23. punktu, kur polimērs ir polikarboffls.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/743,153 US5985861A (en) | 1996-11-04 | 1996-11-04 | Progesterone for treating or reducing ischemia |
| PCT/US1997/020923 WO1998019681A1 (en) | 1996-11-04 | 1997-11-04 | Progesterone for treating or reducing ischemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV12342A LV12342A (lv) | 1999-09-20 |
| LV12342B true LV12342B (lv) | 2000-01-20 |
Family
ID=24987712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-99-88A LV12342B (lv) | 1996-11-04 | 1999-05-28 | Progesterons išēmijas ārstēšanai vai mazināšanai |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US5985861A (lv) |
| EP (1) | EP0956023B1 (lv) |
| KR (1) | KR100434623B1 (lv) |
| CN (1) | CN100341512C (lv) |
| AR (1) | AR009407A1 (lv) |
| AT (1) | ATE321558T1 (lv) |
| AU (1) | AU715740C (lv) |
| BR (1) | BR9710918A (lv) |
| CA (1) | CA2270565C (lv) |
| DE (1) | DE69735598T2 (lv) |
| DK (1) | DK0956023T3 (lv) |
| ES (1) | ES2262196T3 (lv) |
| GE (1) | GEP20022630B (lv) |
| HK (1) | HK1020534A1 (lv) |
| HU (1) | HUP9904045A3 (lv) |
| IL (1) | IL127455A (lv) |
| LV (1) | LV12342B (lv) |
| MA (1) | MA24391A1 (lv) |
| MY (1) | MY121627A (lv) |
| NO (1) | NO324278B1 (lv) |
| NZ (1) | NZ335306A (lv) |
| PE (1) | PE9899A1 (lv) |
| PT (1) | PT956023E (lv) |
| RO (1) | RO120607B1 (lv) |
| UA (1) | UA66772C2 (lv) |
| WO (1) | WO1998019681A1 (lv) |
| ZA (1) | ZA979862B (lv) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6602487B1 (en) | 1997-02-26 | 2003-08-05 | Dimera Incorporated | Methods and tests for producing and for inhibiting coronary artery vasospasms |
| US6056972A (en) * | 1997-02-26 | 2000-05-02 | Dimera, Llc | Method for reducing coronary artery reactivity |
| US20040234606A1 (en) * | 1997-09-12 | 2004-11-25 | Levine Howard L. | Localized vaginal delivery without detrimental blood levels |
| DE69819748T2 (de) | 1997-09-12 | 2004-09-30 | Columbia Laboratories (Bermuda) Ltd. | Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen |
| GB0107383D0 (en) * | 2001-03-23 | 2001-05-16 | Univ Edinburgh | Lipid profile modulation |
| US20080182841A1 (en) * | 2001-10-29 | 2008-07-31 | Levine Howard L | Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
| US8425892B2 (en) | 2001-10-29 | 2013-04-23 | Columbia Laboratories, Inc. | Extended, controlled-release pharmaceutical compositions using charged polymers |
| US20030114394A1 (en) * | 2001-10-29 | 2003-06-19 | Levine Howard L. | Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
| US7572780B2 (en) | 2003-01-21 | 2009-08-11 | Dimera, Incorporated | Method and kit for reducing the symptoms of peripheral vascular disease |
| DE602004026173D1 (de) | 2003-04-29 | 2010-05-06 | Gen Hospital Corp | Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln |
| DE102005027004B4 (de) * | 2005-06-10 | 2020-03-19 | Continental Automotive Gmbh | Scheibenwaschvorrichtung |
| US8828981B2 (en) | 2007-02-06 | 2014-09-09 | George Creasy | Progesterone for the treatment or prevention of spontaneous preterm birth |
| CA3016642A1 (en) | 2008-02-04 | 2009-08-13 | Ferring B.V. | Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| LT2782584T (lt) | 2011-11-23 | 2021-09-10 | Therapeuticsmd, Inc. | Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| KR20170040209A (ko) | 2014-07-29 | 2017-04-12 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 경피 크림 |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| US11512107B2 (en) | 2018-09-07 | 2022-11-29 | Trustees Of Dartmouth College | Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation |
| WO2020051329A1 (en) * | 2018-09-07 | 2020-03-12 | Trustees Of Dartmouth College | C19 scaffolds and steroids and methods of use and manufacture thereof |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1124906A1 (ru) * | 1982-05-25 | 1984-11-23 | Ивановский государственный медицинский институт им.А.С.Бубнова | Способ коррекции ишемических повреждений консервированной донорской почки |
| ATE151286T1 (de) * | 1983-11-14 | 1997-04-15 | Columbia Lab Inc | Bioadhäsive mittel |
| US5543150A (en) * | 1993-09-15 | 1996-08-06 | Columbia Laboratories, Inc. | Method of progesterone delivery and affect thereof |
-
1996
- 1996-11-04 US US08/743,153 patent/US5985861A/en not_active Expired - Lifetime
-
1997
- 1997-11-03 ZA ZA9709862A patent/ZA979862B/xx unknown
- 1997-11-03 MA MA24853A patent/MA24391A1/fr unknown
- 1997-11-04 GE GEAP19974830A patent/GEP20022630B/en unknown
- 1997-11-04 UA UA99052985A patent/UA66772C2/uk unknown
- 1997-11-04 NZ NZ335306A patent/NZ335306A/xx not_active IP Right Cessation
- 1997-11-04 WO PCT/US1997/020923 patent/WO1998019681A1/en active IP Right Grant
- 1997-11-04 BR BR9710918-5A patent/BR9710918A/pt not_active Application Discontinuation
- 1997-11-04 AU AU51801/98A patent/AU715740C/en not_active Ceased
- 1997-11-04 DE DE69735598T patent/DE69735598T2/de not_active Expired - Fee Related
- 1997-11-04 HU HU9904045A patent/HUP9904045A3/hu unknown
- 1997-11-04 PE PE1997000985A patent/PE9899A1/es not_active Application Discontinuation
- 1997-11-04 AT AT97946681T patent/ATE321558T1/de not_active IP Right Cessation
- 1997-11-04 CN CNB971994145A patent/CN100341512C/zh not_active Expired - Fee Related
- 1997-11-04 PT PT97946681T patent/PT956023E/pt unknown
- 1997-11-04 MY MYPI97005220A patent/MY121627A/en unknown
- 1997-11-04 AR ARP970105144A patent/AR009407A1/es unknown
- 1997-11-04 ES ES97946681T patent/ES2262196T3/es not_active Expired - Lifetime
- 1997-11-04 EP EP97946681A patent/EP0956023B1/en not_active Expired - Lifetime
- 1997-11-04 CA CA002270565A patent/CA2270565C/en not_active Expired - Fee Related
- 1997-11-04 DK DK97946681T patent/DK0956023T3/da active
- 1997-11-04 KR KR10-1999-7003965A patent/KR100434623B1/ko not_active IP Right Cessation
- 1997-11-04 RO RO99-00508A patent/RO120607B1/ro unknown
-
1998
- 1998-12-09 IL IL12745598A patent/IL127455A/xx not_active IP Right Cessation
-
1999
- 1999-02-01 US US09/240,610 patent/US6054447A/en not_active Expired - Lifetime
- 1999-05-03 NO NO19992140A patent/NO324278B1/no unknown
- 1999-05-28 LV LVP-99-88A patent/LV12342B/lv unknown
- 1999-11-30 HK HK99105558A patent/HK1020534A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5985861A (en) | Progesterone for treating or reducing ischemia | |
| JP3211892B2 (ja) | 肛門疾患を治療する窒素酸化物供与体及び方法 | |
| RU2330667C2 (ru) | Прогестинотерапия с регулируемым кровотечением | |
| Nilsson et al. | Treatment of menorrhagia | |
| US20040110732A1 (en) | Pharmaceutical composition for transdermal or transmucosal administration comprising at least one progestin and/or at least one oestrogen, process for preparing it and uses thereof | |
| US20070281912A1 (en) | Contraception method | |
| WO2000037071A1 (en) | Topical treatment of skin disease | |
| KR100450649B1 (ko) | 호르몬약물및에스트로겐결핍을치유하기위한그의용도 | |
| Zoma et al. | Effects of combined use of sildenafil citrate (Viagra) and 17β-estradiol on ovine coronary and uterine hemodynamics | |
| JPS6227A (ja) | 皮膚科ならびに眼科用の外傷、潰瘍治療用クリーム剤 | |
| DE60036723T2 (de) | Mesoprogestine zur behandlung und vorbeugung von hormonabhängigen gutartigen gynekologischen störungen | |
| MXPA99004130A (es) | Progesterona para el tratamiento o la reduccion de isquemia | |
| JPS63101326A (ja) | 子宮でのプロスタグランジン合成抑制剤 | |
| Arnt et al. | Low-dose combination oral contraceptives: a controlled clinical study of three different norgestrel-ethinyl estradiol ratios | |
| JP2002503215A (ja) | 虚血を治療又は抑制するためのプロゲステロン | |
| Seeger et al. | Additive antioxidative effect of hormone replacement therapy | |
| UA79421C2 (en) | Progestin therapy with regular menstrual bleeding | |
| JPS597682B2 (ja) | 軟膏基剤 |